⌘K

08:45:12·4d

SECFilingvia Quantisnow

BioMarin Pharmaceutical Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.

BMRN· BioMarin Pharmaceutical Inc.

Health Care

Original source

BioMarin Pharmaceutical Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits | Quantisnow